Lees Pharmaceutical Holdings Financials

Lees Pharmaceutical Stock Summary

Lees Pharmaceutical competes with BCE, CapitaLand Investment, Ameriprise Financial, SEI Investments, and Royalty Management. Lees Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the Peoples Republic of China. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong. Lees Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1182 people.

Lees Pharmaceutical Key Financial Ratios

There are many critical financial ratios that Lees Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Lees Pharmaceutical reports annually and quarterly.

Lees Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Lees Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Lees Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lees Pharmaceutical competition to find correlations between indicators driving Lees Pharmaceutical's intrinsic value. More Info.Lees Pharmaceutical Holdings is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lees Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Lees Pharmaceutical Market Pulse

Along with financial statement analysis, the daily predictive indicators of Lees Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lees Pharmaceutical Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lees Pharmaceutical Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Lees Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lees Pharmaceutical's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

If you are still planning to invest in Lees Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lees Pharmaceutical's history and understand the potential risks before investing.